Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ARPC5L | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
mRNA | PSENEN | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
mRNA | NUP214 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
mRNA | KIAA1586 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | INO80D | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | RPL26 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | ZNF586 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ZNF672 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | GON7 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | SPEN | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |